A UAB research team defines the criteria that CAR immunotherapies for neurodegenerative diseases must meet to advance both conceptually and in trials, which are still at a very preliminary stage, in a review study published in the journal Trends in Pharmacological Sciences.
from News Medical Medical Research News Feed https://ift.tt/7cnHEfC
0 Comments